Human 4-1BB Ligand/TNFSF9 Alexa Fluor® 488-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB22952G
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Arg71-Glu254
Accession # P41273.1
Specificity
Clonality
Host
Isotype
Applications
Flow Cytometry
Sample: Human Daudi cell line
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: 4-1BB Ligand/TNFSF9
4-1BB Ligand binds to 4-1BB/TNFRSF9/CD137 on activated CD4+ and CD8+ T cells, thymocytes, and NK cells as well as on monocytes, neutrophils, DC, and eosinophils. In response to 4-1BB Ligand binding, 4-1BB transduces a co-stimulatory signal that promotes the proliferation, activation, and survival of CD4+ and CD8+ T cells (4, 11, 12). T cell co-stimulation through CD28 is important for the initial T cell expansion, while 4-1BB acts later in the response (12, 13). 4-1BB Ligand function supports the survival and responsiveness of memory T cells during viral infection (13-15). Reverse signaling through 4-1BB Ligand on monocytes induces the production of inflammatory cytokines (5). On macrophages, 4-1BB Ligand associates in cis with TLR4 and enhances inflammatory cytokine production in response to TLR4 ligation (6). Its expression on early myeloid progenitor cells limits the development of dendritic cells, monocytes, and B cells (9).
References
- Wang, C. et al. (2009) Immunol. Rev. 229:192.
- Alderson, M.R. et al. (1994) Eur. J. Immunol. 24:2219.
- Reali, C. et al. (2003) J. Neurosci. Res. 74:67.
- DeBenedette, M.A. et al. (1997) J. Immunol. 158:551.
- Langstein, J. et al. (1998) J. Immunol. 160:2488.
- Kang, Y.J. et al. (2007) Nat. Immunol. 8:601.
- Baessler, T. et al. (2010) Blood 115:3058.
- Gullo, C. et al. (2010) PLoS One 5:e10845.
- Lee, S.-W. et al. (2008) Nat. Immunol. 9:917.
- Salih, H.R. et al. (2001) J. Immunol. 167:4059.
- Wen, T. et al. (2002) J. Immunol. 168:4897.
- Cannons, J.L. et al. (2001) J. Immunol. 167:1313.
- Bertram, E.M. et al. (2002) J. Immunol. 168:3777.
- Bukczynski, J. et al. (2004) Proc. Natl. Acad. Sci. USA 101:1291.
- Lin, G.H.Y. et al. (2009) J. Immunol. 182:934.
Alternate Names
Gene Symbol
UniProt
Additional 4-1BB Ligand/TNFSF9 Products
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only